Basic Sciencemoderate evidence

A human organoid drug screen identifies α2-adrenergic receptor signaling as a therapeutic target for cartilage regeneration.

Cell stem cell·December 5, 2024·PMID 39353427

Why it matters

It identifies a repurposable drug target (α2-AR/SLPI) for cartilage regeneration, addressing the major barrier of hypertrophic degeneration in stem cell-based therapies. This could inform future clinical strategies for osteoarthritis and cartilage defects.

Infographic summary of A human organoid drug screen identifies α2-adrenergic receptor signaling as a therapeutic target for cartilage regeneration.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled